Advanced search
Publication Cover
Emerging Microbes & Infections Volume 7, 2018 - Issue 1
Submit an article Journal homepage
1,873
Views
47
CrossRef citations to date
0
Altmetric
Original Articles

Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis

Manuel KussmannDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
,
Matthias KarerDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
,
Markus ObermuellerDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
,
Katy SchmidtCenter for Anatomy and Cell Biology, Division of Cell and Developmental BiologyMedical University of ViennaViennaAustria
,
Wolfgang BarouschDepartment of Laboratory Medicine, Division of Clinical MicrobiologyMedical University of ViennaViennaAustria
,
Doris MoserDepartment of Cranio-Maxillofacial and Oral SurgeryMedical University of ViennaViennaAustria
,
Marion NehrDepartment of Laboratory Medicine, Division of Clinical MicrobiologyMedical University of ViennaViennaAustria
,
Michael RamharterDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria;Department of Tropical Medicine; Bernhard Nocht Institute for Tropical Medicine & I. Dep. Of MedicineUniversity Medical Center Hamburg-EppendorfHamburgGermany
,
Wolfgang PoepplDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria;Military Medical Cluster EastAustrian Armed ForcesViennaAustria
,
Athanasios MakristathisDepartment of Laboratory Medicine, Division of Clinical MicrobiologyMedical University of ViennaViennaAustria
,
Stefan WinklerDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
,
Florian ThalhammerDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
,
Heinz BurgmannDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustria
&
Heimo LaglerDepartment of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of ViennaViennaAustriaCorrespondence[email protected]
 show all
Pages 1-10 | Received 20 Aug 2018, Accepted 11 Nov 2018, Published online: 05 Dec 2018

References

  • FINAL draft Label - dalvance_pi. https://www.allergan.com/assets/pdf/dalvance_pi. Accessed 11th Sept 2017.
  • ZhanelGGet al.New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancinDrugs201070 859 88610.2165/11534440-000000000-00000
  • ChenAYZervosMJVazquezJADalbavancin: a novel antimicrobialInt J. Clin. Pract.20076185386310.1111/j.1742-1241.2007.01318.x1890846
  • NagarajanRStructure-activity relationships of vancomycin-type glycopeptide antibioticsJ. Antibiot.1993461181119510.7164/antibiotics.46.1181
  • LeightonAet al.Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteersAntimicrob. Agents Chemother.20044894094510.1128/AAC.48.3.940-945.2004353075
  • CavaleriMet al.Pharmacokinetics and excretion of dalbavancin in the ratJ. Antimicrob. Chemother.200555Suppl 2ii31ii3510.1093/jac/dki006
  • BuckwalterMDowellJAPopulation pharmacokinetic analysis of dalbavancin, a novel lipoglycopeptideJ. Clin. Pharmacol.2005451279128710.1177/0091270005280378
  • WerthBJet al.Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen.Clin. Microbiol. Infect.201824429.e1429.e510.1016/j.cmi.2017.07.028
  • GardeteSusanaKimChoonkeunHartmannBoris M.MwangiMichaelRouxChristelle M.DunmanPaul M.ChambersHenry F.TomaszAlexanderGenetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300PLoS Pathogens201282e100250510.1371/journal.ppat.10025053271070
  • HaferCLinYKornblumJLowyFDUhlemannACContribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureusAntimicrob. Agents Chemother.2012565845585110.1128/AAC.01139-123486570
  • KatoYSuzukiTIdaTMaebashiKGenetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSRJ. Antimicrob. Chemother.201065374510.1093/jac/dkp394
  • WatanabeYCuiLKatayamaYKozueKHiramatsuKImpact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureusJ. Clin. Microbiol.2011492680268410.1128/JCM.02144-103147882
  • HowdenBPet al.Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKRPLoS Pathog.20117e100235910.1371/journal.ppat.10023593213104
  • HowdenBPet al.Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureusAntimicrob. Agents Chemother.2008523755376210.1128/AAC.01613-072565880
  • KurodaMet al.Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureusMol. Microbiol.20034980782110.1046/j.1365-2958.2003.03599.x
  • ProctorRAet al.Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infectionsNat. Rev. Microbiol.2006429530510.1038/nrmicro1384
  • Abu-QatousehLFet al.Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotypeJ. Mol. Med.20108856557510.1007/s00109-010-0597-2
  • MelterORadojevičBSmall colony variants of Staphylococcus aureus--reviewFolia Microbiol. (Praha)20105554855810.1007/s12223-010-0089-3
  • TenoverFCet al.Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typingJ. Clin. Microbiol.19953322332239228385
  • SteeleJMSeaburyRWHaleCMMogleBTUnsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancinJ. Clin. Pharm. Ther.20184310110310.1111/jcpt.12580
  • LinYTet al.Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycinJ. Antimicrob. Chemother.2016711807181410.1093/jac/dkw060
  • MoreiraBBoyle-VavraSdeJongeBLDaumRSIncreased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureusAntimicrob. Agents Chemother.1997411788179310.1128/AAC.41.8.1788164006
  • Monteiro, A. de S., et al Effects of Alterations in Staphylococcus aureus Cell Membrane and Cell Wall in Antimicrobial Resistance. In The Rise of Virulence and Antibiotic Resistance in Staphylococcus aureus (IntechOpen, London, 2017). 10.5772/66954
  • HowdenBPJohnsonPDRWardPBStinearTPDaviesJKIsolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremiaAntimicrob. Agents Chemother.2006503039304710.1128/AAC.00422-061563555
  • ZhuXet al.Vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolated from a patient who never received vancomycin treatmentInt. J. Infect. Dis.20153318519010.1016/j.ijid.2014.12.038
  • CorriganRMAbbottJCBurhenneHKaeverVGründlingAc-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stressPLoS Pathog.20117e100221710.1371/journal.ppat.10022173164647
  • CameronDRet al.Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureusJ. Infect. Dis.20122051677168710.1093/infdis/jis2523415852
  • LimKTTehCSJYusofMYMThongKLMutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in MalaysiaTrans. R. Soc. Trop. Med. Hyg.201410811211810.1093/trstmh/trt111
  • FritscheTRRennieRPGoldsteinBPJonesRNComparison of Dalbavancin MIC Values Determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organismsJ. Clin. Microbiol.2006442988299010.1128/JCM.00640-061594606
  • JonesRNet al.Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancinDiagn. Microbiol. Infect. Dis.201582737710.1016/j.diagmicrobio.2015.01.017
  • Dunne, M. W., Sahm, D. & Puttagunta, S. Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies. Ann. Clin. Microbiol. Antimicrob.14, 19 (2015).
  • SinghSSinghSKChowdhuryISinghRUnderstanding the mechanism of bacterial biofilms resistance to antimicrobial agentsOpen Microbiol J.201711536210.2174/18742858017110100535427689
  • KerenIKaldaluNSpoeringAWangYLewisKPersister cells and tolerance to antimicrobialsFEMS Microbiol. Lett.2004230131810.1016/S0378-1097(03)00856-5
  • TandeAJet al.Clinical characteristics and outcomes of prosthetic joint infection caused by small colony variant staphylococciMBio20145e01910e0191410.1128/mBio.01910-144196237
  • Reffuveille, F., Josse, J., Vallé, Q., Mongaret, C. & Gangloff, S. C. (March 8th 2017). Staphylococcus aureus Biofilms and their Impact on the Medical Field, The Rise of Virulence and Antibiotic Resistance in Staphylococcus aureus, Shymaa Enany and Laura E. Crotty Alexander, IntechOpen, 10.5772/66380.
  • FernándezJGreenwood-QuaintanceKEPatelRIn vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infectionsDiagn. Microbiol. Infect. Dis.20168544945110.1016/j.diagmicrobio.2016.05.009
  • DrlicaKZhaoXMutant selection window hypothesis updatedClin. Infect. Dis.20074468168810.1086/511642
  • TobudicSet al.Dalbavancin as primary and sequential treatment for gram-positive infective endocarditis: 2-year experience at the General Hospital of ViennaClin. Infect. Dis.20186779579810.1093/cid/ciy279
  • ShopsinBet al.Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strainsJ. Clin. Microbiol.1999373556356385690
  • KoreenLet al.spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariationJ. Clin. Microbiol20044279279910.1128/JCM.42.2.792-799.2004344479
  • EnrightMCDayNPJDaviesCEPeacockSJSprattBGMultilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureusJ. Clin. Microbiol2000381008101586325
  • HarmsenDet al.Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database managementJ. Clin. Microbiol.2003415442544810.1128/JCM.41.12.5442-5448.2003309029
  • Sharma-KuinkelBKRudeTHFowlerVGPulse field gel electrophoresisMethods Mol. Biol.2016137311713010.1007/7651_2014_1914582012
  • Koeth, L. M., DiFranco-Fisher, J. M. & McCurdy, S. A Reference broth microdilution method for dalbavancin in vitro susceptibility testing of bacteria that grow aerobically. J. Vis. Exp. 103, e53028 (2015).
  • Patel, J. B. et al. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically 10th Ed. (CLSI, Wayne, PA, 2015).
  • The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1 http://www.eucast.org. (2017).
  • KahlBet al.Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosisJ. Infect. Dis.19981771023102910.1086/515238
  • BesierSLudwigAOhlsenKBradeVWichelhausTAMolecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureusInt. J. Med. Microbiol.200729721722510.1016/j.ijmm.2007.02.003
  • McBirneySETrinhKWong-BeringerAArmaniAMWavelength-normalized spectroscopic analysis of Staphylococcus aureus and Pseudomonas aeruginosa growth ratesBiomed. Opt. Express201674034404210.1364/BOE.7.0040345102515
  • SprouffskeKWagnerAGrowthcurver: an R package for obtaining interpretable metrics from microbial growth curvesBMC Bioinformatics20161717210.1186/s12859-016-1016-74837600
  • YamamotoTTakanoTIwaoYHishinumaAEmergence of NDM-1-positive capsulated Escherichia coli with high resistance to serum killing in JapanJ. Infect. Chemother.20111743543910.1007/s10156-011-0232-3
  • de LeónLLópezMRMoujirLAntibacterial properties of zeylasterone, a triterpenoid isolated from Maytenus blepharodes, against Staphylococcus aureusMicrobiol. Res.201016561762610.1016/j.micres.2009.12.004
  • BolgerAMLohseMUsadelBTrimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics2014302114212010.1093/bioinformatics/btu17024695404
  • ZiminAVet al.The MaSuRCA genome assemblerBioinformatics2013292669267710.1093/bioinformatics/btt4763799473
  • DarlingACEMauBBlattnerFRPernaNTMauve: multiple alignment of conserved genomic sequence with rearrangementsGenome Res.2004141394140310.1101/gr.2289704442156
  • OkonechnikovKGolosovaOFursovMUnipro UGENE: a unified bioinformatics toolkitBioinformatics2012281166116710.1093/bioinformatics/bts091

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.